Tickers

Xalles Holdings Inc – Growth and Efficiency Part 2 of 2

Explore how Xalles Holdings Inc. keeps expanding and streamlining in Part 2, showcasing their milestones in growth and operational efficiency.

Xalles Holdings Inc – Growth and Efficiency Part 1 of 2

Delve into how Xalles Holdings Inc. keeps expanding and streamlining in Part 1, showcasing their 2023 milestones in growth and operational efficiency.

Vivos Inc. Innovation in Precision Radionuclide Therapy

Dive into Vivos Inc.'s strategic advancements, from FDA breakthroughs in human cancer therapy to expanding IsoPet® services for pets.

ENZC – Biogenysis Advances in Monoclonal Antibody Patent Race

Biogenysis, a subsidiary of Enzolytics, is pushing the boundaries in monoclonal antibodies with their recent patent applications.

Bloom Energy’s Installation in Taiwan: Tracking BE, FCEL, GEVO Tickers

Bloom Energy has installed its first phase in Taiwan, marking a surge in the global solid oxide fuel cell market. Explore key insights and trends.

Xalles Holdings Reports Record Growth in Q2 2023!

Explore Xalles Holdings' 8th consecutive quarter of growth in Q2 2023, with revenues rising by 21%. Learn about strategic acquisitions and the future outlook.